Markets Briefing
Provention Bio, Inc. (PRVB) Having a Robust Premarket After Abysmal Thursday
Provention Bio, Inc. (PRVB), a clinical stage biopharmaceutical company, has soared 22.06% during the pre-market trading and consequently is trading at $4.15 at the time